UltraGreen.ai Limited (SGX:UGS)

Market Cap	683.24M
Revenue (ttm)	205.05M +41.2%
Net Income	115.44M +62.5%
EPS	0.12 -99.9%
Shares Out	n/a
PE Ratio	5.13
Forward PE	5.95
Dividend	0.01 (2.02%)
Ex-Dividend Date	Aug 20, 2026

Volume	126,100
Open	0.6300
Previous Close	0.6150
Day's Range	0.6200 - 0.6350
52-Week Range	0.6050 - 1.8400
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2026

About UltraGreen.ai

UltraGreen.ai Limited manufactures and sells Indocyanine Green (ICG) pharmaceutical products in the United States and internationally. It provides diagnostic imaging analytics and software solutions. The company also develops software for real-time quantification of blood perfusion during surgery, including PerfusionWorks quantification software for tissue perfusion, lymphatic mapping, and margin assessment. In addition, it offers products, such as ICG, the IC-Flow Imaging System and the UltraGreen Data Platform and other technologies related t...

• Industry: Surgical and Medical Instruments and Apparatus
• Sector: Healthcare
• Founded: 2024
• Employees: 112
• Stock Exchange: Singapore Exchange
• Ticker Symbol: UGS

Financial Performance

In 2025, UltraGreen.ai's revenue was $137.94 million, an increase of 27.70% compared to the previous year's $108.02 million. Earnings were $75.63 million, an increase of 35.15%.

Financial numbers in USD

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 23, 2026

Data Sources Report a data error